Medtronic unveils adaptive deep brain stimulation trial in Parkinson's patients
Medtronic unveils adaptive deep brain stimulation trial in Parkinson's patients Medtronic unveils adaptive deep brain stimulation trial in Parkinson's patients 15 January 2021 | News The randomised study will take place across 12 study sites at leading movement disorders research centers in the US, Europe, and Canada Source: medtronic.com Medtronic plc, the global leader in medical technology, announced the first enrolment in ADAPT-PD (Adaptive DBS Algorithm for Personalised Therapy in Parkinson's Disease), its trial evaluating the safety and efficacy of adaptive deep brain...